Back
The New York Times Co. Vs. Amphastar Pharmaceuticals, Inc. Industry Stock Comparison
Buy
83
NYT
The New York Times Co.
Last Price:
$67.30
Seasonality Move:
5.57%
Sell
41
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$25.63
Seasonality Move:
0.37%
Buy
83
The New York Times Co. (NYT)
is a Buy
Is The New York Times Co. a Buy, Sell or Hold?
-
The current The New York Times Co. [NYT] share price is $67.53. The Score for NYT is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
-
NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
41
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Sell
Is Amphastar Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $26.31. The Score for AMPH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
AMPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NYT Stock Price Chart
What is The New York Times Co.'s stock price today?
-
The The New York Times Co. share price today is $67.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing selling pressure, which indicates risk of future bearish movement.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals, Inc.'s stock price today?
-
The Amphastar Pharmaceuticals, Inc. share price today is $26.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
NYT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.79 | Buy |
| Relative Strength Index (14 RSI): | 73.79 | Buy |
| Chaikin Money Flow: | -2215710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.19 - 66.19) | Buy |
| Bollinger Bands (100): | (55.28 - 63) | Buy |
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 51 | Buy |
| Chaikin Money Flow: | 281725 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.7 - 27.28) | Sell |
| Bollinger Bands (100): | (23.76 - 28.88) | Sell |
NYT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.31 | Buy |
| 20-day SMA: | 65 | Buy |
| 50-day SMA: | 60.63 | Buy |
| 200-day SMA: | 55.77 | Buy |
| 8-day EMA: | 66.63 | Buy |
| 20-day EMA: | 64.96 | Buy |
| 50-day EMA: | 62.14 | Buy |
| 200-day EMA: | 57.21 | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.1 | Buy |
| 20-day SMA: | 26.43 | Sell |
| 50-day SMA: | 25.5 | Buy |
| 200-day SMA: | 25.66 | Buy |
| 8-day EMA: | 26.09 | Buy |
| 20-day EMA: | 26.22 | Buy |
| 50-day EMA: | 26.08 | Buy |
| 200-day EMA: | 27.96 | Sell |
The New York Times Co. Earnings Growth & NYT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.24 per share.
Amphastar Pharmaceuticals, Inc. Earnings Growth & AMPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.51 per share, and an increase next year of $0.29 per share.
The New York Times Co. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amphastar Pharmaceuticals, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||